ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NVS Novartis AG

103.31
0.00 (0.00%)
Pre Market
Last Updated: 10:32:14
Delayed by 15 minutes
Name Symbol Market Type
Novartis AG NYSE:NVS NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 103.31 6 10:32:14

ADR Shares End Lower; SAP Shares Trade Actively

17/07/2014 11:27pm

Dow Jones News


Novartis (NYSE:NVS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Novartis Charts.

International stocks trading in New York closed lower on Thursday. The Bank of New York index of American depositary receipts fell 1.44%, to 155.14. The European index decreased 1.52%, to 153.23; the Asian index dropped 1.35%, to 149.28; the Latin American index fell 1.32%, to 299.7; and the emerging markets index declined 1.43%, to 293.89. Among the companies with shares that actively traded was SAP SE (SAP, SAP.XE).

SAP said that revenue from cloud applications rose rapidly in the second quarter, despite reporting a 23% drop in profit. But investors focused on revenue generated from the German software company's cloud-based products, which jumped 52% and management raised its forecast for full-year cloud revenue. Shares rose 1.3%, to $80.68.

Cemex SAB (CX, CEMEX.MX) shares fell after a report that housing starts in the southern U.S. fell 30% in June. The Mexico-based cement maker has a significant presence in the U.S., and particularly in the south. Shares declined 2.7% to $12.89.

Novartis AG (NVS, NOVN.VX) said strong sales in emerging markets fueled a 2% jump in second-quarter revenue, a performance that comes as the pharmaceutical giant readies for a sweeping overhaul that will narrow its focus. However the results missed expectations. Shares fell 1.7% to $88.53.

Write to Tess Stynes at tess.stynes@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Novartis Chart

1 Year Novartis Chart

1 Month Novartis Chart

1 Month Novartis Chart

Your Recent History

Delayed Upgrade Clock